Innate Pharma SA (IPHYF)
2.13
-0.52
(-19.62%)
USD |
OTCM |
May 03, 16:00
Innate Pharma Price to Book Value: 3.001 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 3.001 |
May 02, 2024 | 3.734 |
May 01, 2024 | 3.734 |
April 30, 2024 | 3.734 |
April 29, 2024 | 3.734 |
April 26, 2024 | 3.734 |
April 25, 2024 | 3.734 |
April 24, 2024 | 3.734 |
April 23, 2024 | 3.734 |
April 22, 2024 | 3.734 |
April 19, 2024 | 3.734 |
April 18, 2024 | 3.734 |
April 17, 2024 | 3.734 |
April 16, 2024 | 3.734 |
April 15, 2024 | 3.734 |
April 12, 2024 | 3.734 |
April 11, 2024 | 3.734 |
April 10, 2024 | 3.734 |
April 09, 2024 | 3.734 |
April 08, 2024 | 3.734 |
April 05, 2024 | 3.734 |
April 04, 2024 | 3.734 |
April 03, 2024 | 3.734 |
April 02, 2024 | 3.734 |
April 01, 2024 | 3.636 |
Date | Value |
---|---|
March 28, 2024 | 3.636 |
March 27, 2024 | 3.298 |
March 26, 2024 | 3.375 |
March 25, 2024 | 3.375 |
March 22, 2024 | 3.375 |
March 21, 2024 | 3.375 |
March 20, 2024 | 3.375 |
March 19, 2024 | 3.375 |
March 18, 2024 | 3.438 |
March 15, 2024 | 3.438 |
March 14, 2024 | 3.438 |
March 13, 2024 | 3.438 |
March 12, 2024 | 3.438 |
March 11, 2024 | 3.438 |
March 08, 2024 | 3.551 |
March 07, 2024 | 3.551 |
March 06, 2024 | 3.551 |
March 05, 2024 | 4.002 |
March 04, 2024 | 4.002 |
March 01, 2024 | 4.002 |
February 29, 2024 | 4.002 |
February 28, 2024 | 4.002 |
February 27, 2024 | 4.002 |
February 26, 2024 | 4.002 |
February 23, 2024 | 4.002 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.223
Minimum
Mar 16 2020
5.136
Maximum
Jan 23 2023
2.513
Average
2.219
Median
May 23 2019
Price to Book Value Benchmarks
DBV Technologies SA | 0.9326 |
Cellectis SA | 2.799 |
PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
Genfit SA | 2.456 |
Price to Book Value Related Metrics
PS Ratio | 3.04 |
Price | 2.13 |
Earnings Yield | -4.54% |
Market Cap | 172.19M |